Methionine-enkephalin in bone and joint tissues

Area of Science:

• Neuroscience
• Orthopedics
• Pharmacology

Background:

• Endogenous opiates like methionine-enkephalin (met-enk) influence cellular and behavioral responses.
• Peptides, including met-enk, have been identified in bone and joint tissues.
• The specific role and distribution of met-enk in these tissues were previously uncharacterized.

Purpose of the Study:

• To investigate the presence, concentration, and distribution of methionine-enkephalin (met-enk) in bone and joint tissues.
• To explore the functional role of met-enk in osteoblast activity and its potential involvement in arthritis.

Main Methods:

• Immunohistochemistry with electron and immunofluorescence microscopy for cellular localization.
• High-performance liquid chromatography with electrochemical detection and radioimmunoassay for concentration analysis.
• Fast atom bombardment mass spectrometry for fragment identification.
• In vitro studies on osteoblast cell growth and in vivo studies using arthritic rat models.

Main Results:

• Methionine-enkephalin (met-enk) was detected in bone marrow, periosteum, ankle joint tissue, and cortical bone.
• Immunohistochemistry revealed cellular and neuronal distribution of met-enk.
• Administration of met-enk inhibited osteoblast cell growth in culture, an effect reversible by naltrexone.
• Concentrations of met-enk were significantly reduced in the ankle joints of arthritic rats compared to controls.

Conclusions:

• Methionine-enkephalin (met-enk) is demonstrably present in bone and joint tissues.
• Met-enk plays a role in regulating osteoblast proliferation.
• Decreased met-enk levels in arthritic joints suggest its involvement in the pathophysiology of adjuvant arthritis.